Cite
HARVARD Citation
Salerno, D. et al. (2022). Two diverse carriers are better than one: A case study in α‐particle therapy for prostate specific membrane antigen‐expressing prostate cancers. Bioengineering & translational medicine. 7 (2), p. n/a. [Online].